Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Final thoughts Stopping GHK-Cu typically produces gradual benefit decline over 2-4 months without dramatic rebound effects or rapid reversal to pre-treatment baseline, with 30-40% of long-term users (6+ months treatment) maintaining 50-70% of peak improvements indefinitely while shorter-term users show greater regression toward baseline
"Nicotinamide N-methyltransferase inhibition mimics and boosts exercise-mediated improvements in muscle function in aged mice." Scientific Reports
TSH/IGF-1 receptor cross talk in Graves ophthalmopathy pathogenesis
AOD-9604 Both are studied in fat-metabolism contexts and sometimes examined together in body-composition research
US$ 23.54
US$ 23.33
US$ 24.45
US$ 27.26
US$ 21.51
US$ 23.89
US$ 25.29
US$ 29.05
US$ 25.10
